the Image

Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email cancerclinicaltrials@bsd.uchicago.edu .

Share this:
Brief Title A Study of Glembatumumab Vedotin in Patients With Advanced Melanoma
Official Title A Phase 2 Study of Glembatumumab Vedotin, an Anti-gpNMB Antibody-drug Conjugate, in Patients With Advanced Melanoma
Principal Investigator Luke, Jason
Brief Summary This study will examine the effectiveness and safety of glembatumumab vedotin in patients with advanced melanoma.
Gender Both
Ages 18 Years
Enrollment 60
Accepts Healthy Volunteers No
Lead Sponsor Celldex TherapeuticsIndustry
Collaborator
Study Design Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Study Phase Phase 2
Study Type Interventional
Contact Name Omid Hamid, MD
Contact Phone 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials)
Condition Melanoma
Detail for Health Professional (on clinicaltrials.gov)
More clinical trials by this PI